Movement disorders arise from the complex interplay of multiple changes to neural circuits. Successful treatments for these disorders could interact with these complex changes in myriad ways, and as a consequence their mechanisms of action and their amelioration of symptoms are incompletely understood. Using Parkinson’s disease as a case study, we review here how computational models are a crucial tool for taming this complexity, across causative mechanisms, consequent neural dynamics and treatments. For mechanisms, we review models that capture the effects of losing dopamine on basal ganglia function; for dynamics, we discuss models that have transformed our understanding of how beta-band (15–30 Hz) oscillations arise in the parkinsonian basal ganglia. For treatments, we touch on the breadth of computational modelling work trying to understand the therapeutic actions of deep brain stimulation. Collectively, models from across all levels of description are providing a compelling account of the causes, symptoms and treatments for Parkinson’s disease.
- parkinson’s disease
Statistics from Altmetric.com
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
The basal ganglia are implicated in a wide range of movement disorders, especially Parkinson’s disease, Huntington’s disease and dystonia. The causes and progression of these disorders are complex, arising from the interplay between multiple changes to neural circuits and between those changes and consequent compensatory mechanisms in the brain. The link between these changes and the resultant overt clinical manifestations is incompletely understood. Available treatments are of limited efficacy and often have poorly defined mechanisms of action. As we aim to show here, one route out of this thicket is to use computational models as a guide to our often faulty intuition.
Parkinson’s disease exemplifies these issues and will be our focus here. Classically, the onset of its cardinal signs (bradykinesia/akinesia, tremor and rigidity) correlates with the loss of midbrain dopamine neurons projecting to the dorsal striatum and especially the putamen in humans. This has long suggested a role for the basal ganglia in motor control and pointed to aberrant basal ganglia dynamics as the root cause of the cardinal motor features. But the basal ganglia are a densely connected web of nuclei (figure 1A). Any change to one neural population in the basal ganglia will have effects that ripple throughout its components; changes to more than one population are impossible to predict with any confidence. Consequently, there is a need for computational models of the parkinsonian basal ganglia to aid our understanding.
There is a rich history of computational modelling of the basal ganglia’s dynamics in their healthy state and of their changes under parkinsonian conditions.1–3 Here we review key insights from such modelling in understanding neural mechanisms of the disease and its symptoms, how its aberrant neural dynamics arise and how its treatments work.
Consequences of dopamine depletion in the striatum
We begin with the striatum. The striatum contains the densest expression of dopamine receptors in the vertebrate brain.4 5 The putamen is also the target of the most vulnerable set of midbrain dopamine neurons in Parkinson’s disease.6 Thus anyone interested in understanding the causes of motor deficits in Parkinson’s disease is naturally drawn to understanding the effects of dopamine depletion on the striatum.
The effects of dopamine receptor activation on a single striatal neuron are subtle and complex.7–9 Experimental studies of the striatal projection neuron have established how dopamine receptor activation downregulates and upregulates a suite of ion channels, both inside and outside of synapses,7 to control the excitability of the neuron. Understanding the interplay between all these effects has required detailed models of single projection neurons that synthesise the findings of many experimental studies.10–12 One contribution of these models has been to provide an intuitive picture of the net effect of activating either D1 or D2 type dopamine receptors and show that these effects cause D1 and D2 expressing projection neurons to respond differently to excitatory input.13 They thus predict that the net effect of dopamine depletion is to change the excitability of projection neurons in opposite directions depending on their expression of D1 or D2 type dopamine receptors (figure 1B). Such models have shown that intuitive arguments about Parkinson’s disease changing the balance of the direct and indirect pathways14 15 have a biophysical basis.
Consistent with the changes to individual neuron dynamics, models of the whole striatal network predict that dopamine depletion profoundly disrupts its normal dynamics. One study suggests that dopamine-depletion increases the spontaneous correlations between projection neuron firing;16 such spontaneous correlated activity could potently block cortical input from being transmitted to striatum and onto the rest of the basal ganglia (figure 1C). Another study suggests that dopamine depletion alters the balance of D1 and D2 projection neuron activity by changing the output of the sparse but powerful inhibitory interneurons.17 Both point to the need to understand how network-scale changes in Parkinson’s disease arise from the cumulative effects of dopamine depletion on individual neurons.
At a broader scale still, models of the whole basal ganglia network have sought to understand the knock-on effects of the depletion of dopamine in the striatum. Many such models test the theory that the basal ganglia’s normal function is to perform action selection through the interaction of the direct and indirect pathways.18 19 Dopamine depletion in these models disrupts the balance of the two striatal output pathways, leading to action selection deficits.20–22 The imbalance could arise either through direct effects on neural excitability, as reviewed above, or through aberrant corticostriatal plasticity that follows dopamine depletion.21 Other models suggest a disruption between the balance of direct and cortico-subthalamic (or ‘hyperdirect’) pathways by dopamine depletion.21 23 Whatever the mechanism, all these models predict a jamming of basal ganglia output, because the direct pathway can no longer induce sufficient inhibition of the basal ganglia output (figure 1D). This lost ability to voluntarily select actions is consistent with the akinetic and bradykinetic features of Parkinson’s disease.
Modelling the effect of losing dopamine neurons on the concentration of dopamine and on D1 and D2 signalling
While the above models seek the consequences of dopamine depletion on the dynamics of the striatum and wider basal ganglia network, others have pursued the equally profound question of how the loss of midbrain dopamine cells creates a complex landscape of adaptations to that loss and subsequent changes in dopamine dynamics during the development of Parkinson’s disease. They suggest that a more nuanced approach is needed to understand the effects of dopamine loss on striatum and thus on basal ganglia function.
One of the simplest but potentially far-reaching predictions of these release models is the phenomenon of passive stabilisation.24 Kinetic models of dopamine release are often used to simulate the interplay between dopamine release and re-uptake.25 26 The loss of dopamine terminals in Parkinson’s disease simultaneously causes a reduction in vesicular release of dopamine and in its re-uptake. Kinetic models predict that the loss of release and of re-uptake are exactly balanced, and as a consequence there is little change in steady-state dopamine tone following the loss of dopamine terminals.24 27 This passive stabilisation of dopamine tone is even more robust if the effects of dopamine autoreceptors on the terminals are simulated, because the autoreceptors act as negative feedback on vesicle release.28 Passive stabilisation of dopamine tone is also seen in detailed reaction-diffusion models of dopamine release that emulate the volume transmission of dopamine throughout a three-dimensional region of the striatum (figure 2A).29–31 Thus several lines of modelling predict that passive stabilisation maintains a normal dopamine tone despite the loss of dopamine neurons (figure 2B and C).
Passive stabilisation seemingly provides a simple hypothesis24 27 for why the cardinal signs of Parkinson’s disease develop after substantial loss of midbrain dopamine neurons. The motor features of Parkinson’s disease are often thought to be a consequence of a gradual loss of dopamine tone; from this perspective, the delayed appearance of the motor signs of Parkinson’s disease could be explained as a consequence of this passive stabilisation of dopamine tone.
This cannot though be the whole story. Whereas postmortem and imaging studies estimate that a loss of dopaminergic neurons and terminals on the order of 50% correlates with the emergence of parkinsonian motor features,6 32 detailed volume transmission models predict that dopamine tone would still be stabilised with a nearly complete loss of dopamine neurons and terminals.31 33 As an example, figure 2C shows these models predict that losing 85% of the dopamine terminals has no detectable effect on dopamine tone. Volume transmission models instead predict that the onset of the cardinal signs of Parkinson’s disease is a consequence of the degraded phasic variations in dopamine concentration against this stabilised background tone.
Phasic variations in dopamine concentration arise because dopamine neurons deviate around their constant spontaneous activity with brief bursts or pauses (figure 2B). These phasic changes in firing can be elicited by unexpected rewards and events,34–36 which may act as a teaching signal that controls synaptic plasticity in the striatum.37–40 Phasic changes in both the firing of dopamine neurons in the lateral substantia nigra pars compactaS41 and the activity of dopaminergic axons in the dorsal striatumS42 also correlate with movement. Volume transmission models of dopamine in the intact striatum show that these bursts and pauses in activity are translated with high fidelity into phasic increases and decreases in dopamine concentration29 30 (figure 2B). However, they also show that the loss of dopamine terminals inevitably decreases how effectively bursts and pauses of activity can change dopamine concentration (figure 2C).31
Supplementary file 1
These models predict that because the dopamine tone is passively stabilised, but phasic changes in dopamine are blunted, so the phasic variations become more difficult to distinguish from mere fluctuations in dopamine tone as more dopamine neurons are lost. This reduction in the signal-to-noise ratio of phasic dopamine becomes notable at moderate loss of dopamine terminals, consistent with the predicted scale of loss of dopamine neurons and terminals at which parkinsonian motor features are first observed.6 32 S43 The models predict that it finally becomes impossible to distinguish phasic events from random fluctuations in baseline dopamine tone at around 80% loss of terminals31 (figure 2C). In addition, as the magnitude of the phasic variations in dopamine decrease with the loss of dopamine neurons, the dopamine receptors are likely to increase their sensitivity to compensate. The combined effect of reduced signal-to-noise ratio and increased receptor sensitivity is thus predicted to be aberrant activation of the D1 and D2 receptors, uncoupled from external events.
This aberrant activation has potentially many functional consequences. On the one hand, dopamine-mediated teaching signals would be missed or random fluctuations treated as teaching signals, both leading to aberrant synaptic plasticity in striatum. On the other hand, if phasic variations in dopamine act as a signal to initiate movement,S41 S42 then losing the ability to detect phasic changes would slow or impair the initiation of movement.
The volume transmission models also predict that the breakdown of passive stabilisation after massive loss of terminals is not homogeneous, as it creates isolated volumes of tissue that contain no dopamine innervation.31 These dopamine voids are predicted to create local imbalances in striatum, as neurons within neighbouring regions of intact and depleted dopamine interact. The volume transmission models thus point to a dual-faced nature of dopamine denervation in Parkinson’s disease, first through loss of phasic dopamine dynamics and later through the creation of dopamine voids, raising the possibility that symptoms and signs arise by these different mechanisms acting concurrently in different areas of the striatum.
A key insight from computational models is that striatal neurons expressing the D1 and D2 receptors are differentially sensitive to the loss of dopamine terminals.11 Modelling suggests that D1 receptors will respond strongly to phasic peaks in dopamine concentration, driven by bursts of spikes at up to 30 Hz; by contrast, models predict that D2 receptors respond to phasic dips in dopamine concentration, driven by pauses in the 4 Hz spontaneous rate of spiking.11 12 As these downward deflections in firing rate are bound below by zero, so the D2 receptors have a worse signal-to-noise ratio for detecting phasic dopamine events even in the intact striatum (figure 2B). Consequently, models predict that D2 receptors will be more sensitive to the loss of dopamine terminals.31 33 S41 These predictions are consistent with the early remodelling of D2-expressing striatal projection neurons in rodent models of Parkinson’s disease.S44
Detailed kinetic models also allow us a better understanding of levodopa’s (L-DOPA) therapeutic actions and side effects. Network models of the striatum simulate L-DOPA as a global increase in dopamine.19 21 S45 Such models predict that a side-effect of L-DOPA would be to raise dopamine tone above normal levels in striatal regions that had not lost dopamine terminals. Detailed release models more accurately simulate L-DOPA as an increase in the number of dopamine molecules released by vesicles in remaining terminals.31 33 In direct contrast to the network models, these release models predict little effect in healthy regions of the striatum due to autoreceptors regulating release at dopamine terminals. In denervated regions, release models predict that L-DOPA’s increase of vesicles allows both partial restoration of dopamine tone and improved separation of phasic dopamine release from background tone.31 As these models also capture homeostatic changes in receptor sensitivity, a future avenue for work could be to examine the consequences of on-medication periods for dopamine signalling in subsequent off-medication periods, in order to dig deeper into the origins of L-DOPA’s side effects.
Mechanisms of parkinsonian neural oscillations
Our clearest glimpse of the neural dynamics in the parkinsonian basal ganglia has come from recordings obtained during surgery to implant electrodes for deep brain stimulation. Recordings from such electrodes placed in the subthalamic nucleus (STN) have revealed a prominent 15–30 Hz ‘beta-band’ oscillation in the local field potential, a signature of co-ordinated synaptic activity.S46 S47 The strength of beta-band oscillation correlates with motor-deficit severity, is suppressed by dopamine-replacement medication, and the magnitude of its suppression is correlated with the degree of improvement in movement.S48 S49 Consequently, the questions of how and where such an oscillation arises have driven a rich vein of modelling work.
Modellers have pursued three broad hypotheses for the origin of the beta-band oscillation. The first and most popular has been the negative feedback loop between the excitatory STN and the inhibitory external globus pallidus (GPe). Modellers have long found this loop intriguing because delayed negative feedback loops are a classic electrical circuit design for oscillators; perhaps unsurprisingly, models of the STN-GPe loop have been shown to generate oscillations under a wide range of conditions, both healthy and parkinsonian.20 S50–S52
By what mechanisms does this loop produce oscillations under parkinsonian conditions of dopamine depletion? Models have uncovered multiple mechanisms that can cause this loop to shift from stable to oscillatory activity,22 but two have been prominently explored because they could plausibly follow from the loss of dopamine. One mechanism is the strengthening of the effect of input from D2-receptor striatal projection neurons to the pallidum,S50 possibly due to the increased excitability of D2 projection neurons (which is a predicted consequence of dopamine loss, as noted above). The second mechanism is the strengthening of the connections between STN and GPe,20 possibly because presynaptic D2 receptors that prevent transmitter release in these nuclei are no longer activated after dopamine depletion.20 Either alone or in combination, both these mechanisms switch the STN-GPe loop from stable to oscillating.
While there are many routes to making the STN-GPe loop oscillate, models have shown that specifically producing oscillations in the beta-band requires a more limited set of conditions. Analytical models from Bogacz and colleagues S53 S54 showed that beta-band oscillations can arise if the total delays in transmission between the STN and GPe are set within a narrow range. Biophysical models of the STN-GPe loop also require setting specific transmission delays to obtain beta-band oscillations.S55 This raised the question of whether the transmission delays in the real primate basal ganglia meet these conditions. Recently, building on their detailed model of primate basal ganglia,S56 Lienard and colleaguesS57 searched for the set of transmission delays that allowed their model to replicate a range of electrophysiological data in healthy primates. With their found set of delays in hand, they then made their model parkinsonian, by increasing the strength of connections between STN and GPe, and beta-band oscillations emerged. Models thus show that beta-band oscillations in the basal ganglia of primates can emerge from the STN-GPe loop. But a challenge to this idea is that while rodent models of Parkinson’s also show beta-band oscillations within STN,S58 computational models suggest the STN- GPe loop in rodents naturally oscillates at higher frequencies;20 this suggests beta-band oscillations in rodents have their origin outside the STN-GPe loop.
Modellers have thus pursued a second hypothesis that proposes beta-band oscillations are generated by the full loop from cortex through the basal ganglia and back to cortex (via thalamus; figure 1A). In these models, beta-band oscillations arise because dopamine depletion either changes basal ganglia control over the thalamo-cortical loop, causing it to oscillate at beta-band frequencies which are then input to the basal ganglia via cortex;S59–S61 or it causes an imbalance between the two cortical loops running via the direct and hyperdirect pathways, which leads to a network-wide oscillation when the total gain in the hyperdirect pathway is sufficiently larger than in the direct pathway.23 Either way, these models predict that such oscillations emerge from a diffuse network of brain structures, rather than a single loop.
A third hypothesis is that beta-band oscillations emerge through changes within the striatum. One plausible scenario explored by Damodaran and colleaguesS62 is that the change in balance of D1 and D2 projection neuron activity caused by dopamine depletion is matched by an increase in output from the inhibitory fast-spiking interneurons in order to downregulate the projection neurons. Their biophysical modelS62 predicts that this causes the projection neurons to become entrained by interneuron output within the beta-band frequencies. Another plausible scenario is that dopamine-depletion leads to synchronised pauses in the fast-spiking interneuron activity that allow the projection neurons to burst at beta-band frequencies.S63 These models have made plausible the idea of striatal-based mechanisms for the generation of oscillatory activity in the beta-band; it remains to show that these oscillations can then spread to the rest of the basal ganglia nuclei as observed in animal model and human patient recordings.
The diversity of modelling explanations for the origin of beta-band oscillations reflects the complexity of the underlying circuit, with its multiple loops and varied neuronal dynamics. The diversity of models also reflects the need, oft-ignored, to be careful in specifying which species is being modelled. After all it is clear that the oscillations in the STN differ between human patients, rodents with their equivalent 15–30 Hz beta-band that requires large unilateral lesions of dopamine neurons to obtainS58 S64 and primates with their ‘low’ beta-band (<15 Hz) in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) model of Parkinson’s disease.S65 Indeed it seems likely that different species will have different underlying causes for their beta-band oscillations, not least because the transmission delays between the basal ganglia nuclei scales with the size of the brain. Some explicit species-specific models of rodent20 22 and primateS56 basal ganglia exist, providing a foundation with which to meet this challenge. A further challenge is that not all patients display beta-band oscillations; thus there remains considerable theoretical work needed to link the presence of such oscillations to specific symptoms.
Mechanisms of deep brain stimulation therapy for Parkinson’s disease
The now routine use of deep brain stimulation for treating the cardinal motor signs of Parkinson’s disease has proved remarkably effective. But this effectiveness has raised a host of questions over its mechanisms of action and effects on the brain, questions that have inspired many computational modelling efforts. The majority of these models have studied high frequency stimulation of the STN, as this has emerged as the primary clinical target for deep brain stimulation therapy.
One class of models have sought to separate the hypotheses of deep brain stimulation exciting or inhibiting (functionally lesioning) the neurons in the target region.S66 To do so, these models have studied the effects of simulated deep brain stimulation current pulses on a detailed model of a single neuron and its axon cable (see Rubin et al 1 for further review). The models have primarily revealed axonal effects,S67 whereby the stimulation pulses entrain action potentials directly in the axons immediately surrounding the electrode. Such models predict that deep brain stimulation thus regularises the output of the STN.
Many models have explored the effects of high-frequency stimulation of the STN on the STN-GPe loop, and how their combined output in turn alters internal globus pallidus (GPi) output to thalamus. One notable class of models here embodies the theory that high-frequency entrainment of the STN ultimately restores function to the thalamus by regularising GPi output.S68 S69 These models show that the parkinsonian bursting activity in STN and GPe is transmitted through the GPi to thalamus and disrupts the passing of information through thalamus (figure 3A). They predict that high-frequency entrainment of STN neurons in turn entrains GPi output to the same regular frequency; the suppression of GPi burst firing restores information transmission through the thalamus (figure 3A).
Another set of models have looked at the heterogenous effects of STN high-frequency stimulation when scaling up to the whole network.S70 These models start from the idea that within a volume of tissue, the strength of stimulation drops off with distance from electrode,S70 and so the response of the simulated STN neurons is heterogeneousS71 S72 (In contrast, the STN-GPe models exploring the regularisation hypothesis are typically very small and assumed homogeneous activation of STN by the electrode.) Such heterogeneous responses in simulated STN lead to heterogeneity in the changes to the firing and burst rate of GPi neurons, S71 S72 which replicate the heterogeneity of changes recorded from primate GPi during high-frequency stimulation of the STN. S73 S74 The model of Humphries and GurneyS71 predicts that deep brain stimulation of the STN restores a natural output balance to the GPi (figure 3B), because these heterogeneous responses in STN ultimately restore the balance of excitatory (via STN) and inhibitory (via GPe) input to GPi neurons. A similar effect of restoring the balance of STN and GPe input to GPi was replicated in a recent detailed biophysical model.S61 These network-scale models also provide a clue as to why 100 Hz is typically the minimal clinically effective stimulation frequency: only above this frequency did a significant proportion of simulated GPi neurons become restored to their pre-parkinsonian state. S61 S71
Recent theoretical work has added an important new idea: short-term depression. Experiments using high-frequency stimulation of the STN in rodents and primates report both a decreased magnitude and increased latency of response in targets of the STN over the duration of the stimulation.S75 Rubin and colleaguesS75 showed they could account for these experimental results using a model in which each stimulation pulse causes a short-term depression in the likelihood of both STN axonal spikes and synaptic release in response to future pulses. The model predicts that under high-frequency stimulation this short-term depression is cumulative, leading to the observed reduction in response and increased latency in the STN’s targets. Importantly, their model predicted that such short-term depression would suppress the transfer of low-frequency oscillations from the STN to the GPe and GPi, by preventing STN axonal spiking from tracking oscillatory input to the STN. Confirming this prediction, they showed their model of short-term depression replicated the suppression of beta-band oscillations in the GPi by high-frequency stimulation of the STN in MPTP primates.S76 If correct, this theory of short-term depression has potential to inform more efficient designs of therapeutic stimulation patterns.
The diversity of modelling approaches here reflects the multiscale nature of understanding deep brain stimulation. These models run the gamut from the effects of stimulation on a single axon, through to detailed models scaling up these predicted regularisation effects to the scale of a small network and on to larger network models that deal with the inevitable heterogeneity of effects on the scale of entire nuclei. The regularisation and network models make different predictions for the therapeutic mechanism of deep brain simulation. In principle, these could be tested with optogenetic mimicking of the patterns of STN neuron recruitment in animal models. However, this would require development of opsin channels that can track the high frequencies needed for therapeutic deep brain stimulation and so produce time-locked action potentials at 90 Hz and above. (Unfortunately, prior work using optogenetics to mimic deep brain stimulationS77 was uninformative, as the opsin used could not track stimulation above 70 Hz.S71) A further hypothesis yet to be explored by computational models is that deep brain stimulation of the STN achieves its therapeutic action by antidromic stimulation of motor cortex.S78 S79
Open questions and fruitful paths
The computational modelling work we have reviewed reflects two different modelling philosophies. In one philosophy, models are constructed based on ideas of neural function and then biophysical changes wrought by a disorder are emulated and the consequences for that function observed. Here we have seen that models of how the basal ganglia control action selection and decision-making develop Parkinson’s like changes following emulated dopamine depletion. In the other philosophy, the goal of the models is to understand the dynamics of neurons under disease, as a prelude to treating those dynamics, irrespective of the function they subserve—such as the models of beta-band oscillations. Both philosophies contribute to our ultimate goal of understanding the mechanisms of Parkinson’s disease and its effective treatments.
Many puzzles remain in our understanding and treatment of Parkinson’s disease.S80 One is what other targets of treatment within the basal ganglia are viable. In a recent biophysical basal ganglia model, Lindahl and Hellgren-Kotaleski22 explored this question. Dopamine depletion produced synchrony and oscillations throughout their model: their innovative approach was to then systematically test which changes to the model damped these oscillations and synchrony. One insight was that, because this model assumed a cortically generated source for the beta-band oscillations, it predicted an increase in the strength of cortical input to the D2 projection neurons would suppress the transmission of beta-band oscillations through the basal ganglia. In contrast, the models that hypothesise an origin of beta oscillations in the STN-GPe loop predict that the same increase in strength would worsen beta-band oscillations. Collectively, these models have thus identified a potentially key deciding parameter between the theories of how beta-band oscillations are generated.
There are many other puzzles amenable to computational insights, of which we touch on a few here:
Dopamine is depleted throughout the basal ganglia, not just in striatum—what are the effects of this extrastriatal loss of dopamine? One hypothesis arising from modelling work is that dopamine actively decouples the STN-GPe loop;20 its recoupling by the loss of dopamine could be a main cause of beta-band oscillations.S53 The effects of dopamine depletion on plasticity at synapses outside the striatum are also largely unexplored (but see ref. 21).
How do realistic changes in dopamine release, predicted by detailed models,33 affect the neural dynamics of the basal ganglia? What are the predicted functional consequences?
What effect does lesion surgery for the treatment of Parkinson’s diseaseS81 S82 have on the dynamics of the basal ganglia and wider corticobasal ganglia loops? Computational models have yet to properly address the consequences of lesions on the dynamics of the Parkinsonian basal ganglia. Partly, this is because the effects would be trivially catastrophic in most models—removing an entire nucleus (such as the GPi) would not restore normal dynamics, but render the model non-functional because it pushes the basal ganglia’s dynamics far from the healthy state. For example, in all the models of beta-band oscillations reviewed above, it is trivially obvious that removing the STN would stop the beta oscillations. But it would also trivially move the dynamics of the GPe (and GPi) very far from the nominally healthy state. Thus, from a computational perspective, why lesion surgery is effective is as much a mystery as deep brain stimulation. One potential line of investigation is that the restoration of motor function after unilateral lesion implies some interhemispheric process restoring normal brain dynamicsS83—yet we know little about, and so have no models of, interhemispheric interactions of the basal ganglia. Another line of investigation, explored in a few studies to date,21 S84 is that lesions are not trivially destructive if crucial mechanisms, such as learning, take place outside the basal ganglia; in these studies, lesioning of a basal ganglia nucleus from a parkinsonian model restores some capacity to learn.
How are the loss of dopamine and the changes in neural dynamics coupled over time? Typically, computational models are switched between discrete baseline and parkinsonian states. However, dopamine neurons are lost continually, and the compensatory mechanisms that are evoked are likely also continuous. Studies in animal models over the course of dopamine loss as they are rendered parkinsonian have suggested a complex temporal relationship between the loss of dopamine neurons and the emergent changes in oscillations, synchrony and firing rates,S85 S86 pointing to the need for computational models to make predictions about the causal sequence of neural changes.
How might we design more efficient forms of deep brain stimulation? Standard stimulation protocols, of a constant, regular train of pulses at above 100 Hz, are both a blunt (if effective) tool and wasteful of battery life. A solution would be some form of closed loop deep brain stimulation, in which key signatures of parkinsonian dynamics are used to trigger stimulation pulses that suppress the aberrant dynamics. Both animal model studiesS87 and preliminary human trialsS88 have provided evidence that closed-loop deep brain stimulation could indeed be more effective than standard, open-loop, protocols. An alternative to closed-loop is better targeting of the stimulation; notable here is Peter Tass’ theoretical proposal of co-ordinated reset, where multiple locations are randomly stimulated to reset pathological oscillationsS89—which progressed to human proof-of-principle trials.S90 Further computational modelling would be able to answer many questions here, including finding the best signatures for triggering closed-loop stimulation and working out the most effective and efficient forms of that feedback stimulation.
Models are intended to be abstractions of reality. To aid understanding, they intentionally omit detail and simplify complex, messy biological mechanisms. They are eternally out of date: for example, the discovery of multiple neuron populations within the rodent GPe,S64 S91 S92 each making a distinct set of connections within the basal ganglia, has made the study of the beta-band oscillations far more complex.S93 The goal of computational models is to be a crutch to our feeble understanding, by forcing us to turn words into exact meanings, to examine our assumptions and to reach further than can our minds alone.
Contributors MDH wrote the outline. MDH and JKD wrote the first draft. All authors contributed to the final draft.
Funding MDH is funded by a Medical Research Council (MRC) Senior non-Clinical Fellowship(MR/J008648/1). JKD is funded by the Lundbeck foundation (Grant #2013-12906).
Competing interests None declared.
Patient consent Not required.
Provenance and peer review Commissioned; externally peer reviewed.